NCM
BIIB icon

Nelson Capital Management’s Biogen BIIB Stock Holding History

Nelson Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed -$1K – 307
2018
Q4 		$1K Hold
3
– – ﹤0.01% 275
2018
Q3 		$1K Buy
+3
New +$1.03K ﹤0.01% 280
2018
Q1 		– Sell
-3
Closed -$1K – 268
2017
Q4 		$1K Buy
+3
New +$962 ﹤0.01% 312
2016
Q3 		– Sell
-50
Closed -$12K – 250
2016
Q2 		$12K Buy
+50
New +$13.2K ﹤0.01% 202

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nelson Capital Management's BIIB Position: Q1 2019 in Review

Nelson Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 3 shares — an estimated $1K sold.

Nelson Capital Management first reported a position in BIIB in Q2 2016 and held it in 4 quarters. The position peaked at $12K in Q2 2016. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Nelson Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Nelson Capital Management sold 3 Biogen shares in Q1 2019, an estimated $1K.
  • Nelson Capital Management first reported a position in Biogen in Q2 2016 and held it in 4 quarters.
  • Nelson Capital Management's Biogen position peaked at $12K in Q2 2016.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Nelson Capital Management's 13F filing for Q1 2019, filed 9 May 2019.